Pharma Archives - Page 13 of 79 - Life Sciences Times

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

THIS WEEK'S STORIES

bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Roots

September 18, 2025

FDA Approves Johnson & Johnson’s INLEXZO™ for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

September 16, 2025

Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring

September 16, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema

Nuvation Bio Gains Japan Approval for IBTROZI in Advanced ROS1-Positive Lung Cancer

Deciphera Wins European Commission Approval for ROMVIMZA in Treating Tenosynovial Giant Cell Tumor

Rubedo Life Sciences Receives FDA Clearance for IND of RLS-1496 in Actinic Keratosis and Expands Clinical Advisory Board

Astria Therapeutics Announces Positive Phase 1a Results for STAR-0310, Supporting Potential Best-in-Class OX40 Antagonist

Most Read

Salt AI Secures $10M to Push Contextual AI in Life Sciences

WHOOP Bolsters Exec Team With New Creative and Legal Chiefs

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

EDITOR PICKS

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

THIS WEEK'S STORIES

bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Roots

FDA Approves Johnson & Johnson’s INLEXZO™ for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring

POPULAR CATEGORY

ABOUT US

FOLLOW US